Prime Endoscopy Bristol Diagnostic solutions

flexible sigmoidoscopy

  • wait

    NHS Not Meeting Recommended Waiting Times

    Last week it was reported that an increasing number of patients are not receiving diagnostic tests within the NHS’s recommended waiting times. The tests, which include x-rays, ultrasounds, colonoscopies and sigmoidoscopies, amongst others, are all aimed at detecting disease, disorder and injury, and if not carried out swiftly could ¬†significantly impact on the patient’s prognosis. […]

  • cancer21

    Worrying Direct Access Figures

    The government’s ¬£750 million cancer strategy for England, which was unveiled in December 2010, had a very definite emphasis on early diagnosis. And as part of the drive to save an additional 5,000 lives a year by 2014/15, it was prescribed that GPs would be able to send patients for direct access to scans, such […]

  • consultation1

    JAG Consultation on Reprocessing of Flexible Endoscopes

    The Joint Advisory Group on GI Endoscopy (JAG), recently announced the completion of their short consultation period for the draft ‘Reprocessing of flexible endoscopes – management and decontamination CFPP 01/06’ (previously HTM01/06). The final document is expected to be approved shortly and once it has been signed off it will be available on the JAG […]

  • people

    Bowel Cancer Awareness Still Low

    The BBC today reported that awareness about bowel cancer is still “stubbornly low” – despite it being the second biggest cause of cancer deaths in the UK. The findings came from a survey carried out by Cancer Research UK which demonstrated that many people did not know that lifestyle factors such as diet, weight and […]

  • prime-endoscopy-bristol-logo-square

    Single flexible sigmoidoscopy screening associated with reduced colorectal cancer

    A single flexible sigmoidoscopy screening between the ages of 55-64 years is associated with a lower level of colorectal cancer (CRC) incidence and mortality, according to a study published in the Journal of the National Cancer Institute. Multiple randomized controlled trials have shown that fecal occult blood testing (FOBT) in CRC screening can reduce the […]